A mixture of antioxidants and fatty acids improves the viability of cultured rat hepatocytes untreated or treated with doxorubicin

Toxicology in Vitro

Volumn 11, Issue 6, 1997, Pages 753-759

  Gokhale, M S ^a   Lin, J R ^a   Yager, J D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cell viability; Doxorubicin; Fatty acids; Pyruvate; Rat hepatocytes; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CARBON TETRACHLORIDE; DOXORUBICIN; FATTY ACID; PYRUVATE SODIUM;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MIXTURE; EGG YOLK; LIVER CELL CULTURE; LIVER TOXICITY; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0030829254     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(97)88948-5     Document Type: Article

References (23)

1. Arterburn L. M., Zurlo J., Yager J. D., Overton R. M. and Heifez A. H. (1995) A morphological study of differentiated rat hepatocytes in vitro. Hepatology 22, 175-187.
2. Baur G., O'Connel C., Devereux D. and Martin A. (1994) Reversal of doxorubicin impaired wound healing using triad compound. American Surgeon 60, 455-459.
3. Bonadonna G., Monfardini S., Delena M. D., Fossati-Bellani F. and Beretter G. (1970) Phase I and preliminary phase II evaluation of Adriamycin (NSC-123127). Cancer Research 30, 2572-2582.
4. Chabner B., Allegra C. J., Curt G. A. and Calabresi P. (1996) Antineoplastic Agents. Goodman & Gilman's The Pharmacological Basis of Therapeutics. pp. 1233-1287. McGraw-Hill, Health Profession Division, NY.
5. Comporti M. (1985) Biology of disease: Lipid peroxidation and cellular damage in toxic liver injury. Laboratory Investigation 53, 599-623.
6. Ellis L. C. (1990) Free radicals in tissue culture: part II. Art to Science in Tissue Culture, Hyclone Laboratories, Inc. 9, 1-6.
7. Fisher A. B. (1987) Intracellular production of oxygen derived free radicals. Upjohn Symposium on Free Radicals pp. 34-38.
8. Goeptar A. R., Scheeren S. H. and Vermeulen N. P. (1995) Oxygen and xenobiotic reductase activities of cytochrome P-450, Critical Reviews in Toxicology 25, 25-65.
9. Icho T., Kojima S., Yoshikawa K., Yoshimura T., Shirota M., Kajiwara Y., Kitabatake K. and Kubota K. (1994) Inhibition of carbon tetrachloride-induced hepatotoxicity by neopterins. Biological Pharmacology Bulletin 17, 914-916.
10. Le Bot M. A., Begue J. M., Kernaleguen D., Robert J., Ratanasavanh D., Airiau J., Riche C. and Guillouzo A. (1988) Different cytotoxicity and metabolism of doxorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes. Biochemical Pharmacology 37, 3877-3887.
11. Maellaro E., Del Bello B., Sugherini L., Pompella A., Casini A. F. and Comporti M. (1994) Protection by ascorbic acid against: oxidative injury of isolated hepatocytes. Xenobiotica 24, 281-289.
12. Martin A. (1996) The use of antioxidants in healing. Dermatologic Surgery 22, 156-160.
13. Matsushita Y., Iguchi H. and Kiyosaki T. (1983) A high performance liquid chromatography method of analysis of 4′o-tetrahydropyranyladriamycin and its metabolites in biological samples. Journal of Antibiotics (Japan) 36, 880-886.
14. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63.
15. Nath K. A., Enright H., Nutter L., Fischereder M., Zou J. N. and Hebbel R. P. (1994) Effect of pyruvate on oxidant injury to isolated and cellular DNA. Kidney International 45, 166-176.
16. Promega (1996) Technical Bulletin No. 169. Madison, WI.
17. Recknagle R. O. and Glende E. A. (1973) Carbon tetrachloride hepatotoxicity. CRC Critical Reviews in Toxicology 27, 263-296.
18. Riley C. A., Crom W. R. and Evans W. E. (1985) Loop column extraction and liquid chromatographic analysis of doxorubicin and three metabolites in plasma. Therapeutic Drug Monitoring 7, 455-460.
19. Sanford K. K., Parshad R. and Gantt R. (1986) Responses of human cells in culture to hydrogen peroxide and related free radicals generate by visible light: relationship to cancer susceptibility. In Free Radicals: Aging and Degenerative Diseases, pp. 373-394. Alan R. Liss, New York.
20. Seglen P. O. (1976) Preparation of isolated rat liver cells. Methods in Cellular Biology 13, 30-83.
21. Thayer W. S. (1984) Serum lipid peroxides in rats treated chronically with adriamycin. Biochemical Pharmacology 33, 2259-2263.
22. Young R. C., Ozols R. F. and Myers C. E. (1981) The anthracyclin antineoplastic drugs. New England Journal of Medicine 305, 139-153.
23. Zurlo J. and Arterburn L. M. (1996) Characterization of a primary hepatocyte culture system for toxicological studies. In Vitro Cellular Developmental Biology-Animal 32, 211-220.